Y&T Frontman DAVE MENIKETTI Diagnosed With Prostate Cancer | News @ METAL.RADIO.FM
Wednesday, 27 November 2024 18:27

Y&T Frontman DAVE MENIKETTI Diagnosed With Prostate Cancer



y&tdave meniketticlassic rock
14:00 Saturday, 19 February 2022
Y&T Frontman DAVE MENIKETTI Diagnosed With Prostate Cancer

Y&T recently rescheduled tour dates due to frontman Dave Meniketti having to undergo an undisclosed "critical medical procedure" on February 11th.

Meniketti posted the following update on social media on February 18th:

"After numerous blood tests, an extensive MRI, and last Friday's biopsy, I have been diagnosed with Prostate cancer. My doctor says we caught it early and the likelihood of surviving this is very high. Over 90% of patients with this type of cancer (thankfully mine is relatively slow growing) are cured and live out their life expectancy. Having spent a lifetime of staying on top of my health, and having caught this early, may be the reason why I should fully survive this.

I urge everyone to listen to your bodies & get regular checkups. I know plenty of people that didn't do that, and it has been the difference between an extended life and death.

Concerning how this affects upcoming shows, the Santa Cruz and Tracy Theatre shows will be unaffected by this and will go on as planned. But because of my lengthy treatment schedule, coming after those shows, we must cancel the Phoenix, Las Vegas, Hollywood, and San Juan Capistrano shows. Check the Y&T tour dates page for updates. We're expecting all other shows to remain intact.

Though I'm generally not a person that believes entertainers need to share their medical issues in public, I felt it was just too hard to keep everyone in doubt… especially since many of you have been with us for Y&T's almost 50-year career and are like extended family.

Regardless of this news, I am doing fine, feeling well, and look forward to getting this behind me and continuing to bring the music to you for many years to come."

Check out the complete Y&T tour schedule here.





by
from